AAPL   322.12 (+1.26%)
MSFT   183.32 (+0.83%)
FB   228.85 (-0.13%)
AMZN   2,421.97 (+0.48%)
NVDA   345.23 (+1.24%)
CGC   21.24 (+6.73%)
BABA   202.01 (+0.41%)
MU   47.51 (-3.92%)
GE   6.85 (-6.17%)
TSLA   815.87 (-0.53%)
ACB   15.56 (+1.70%)
F   5.92 (-1.99%)
DIS   117.48 (-3.34%)
NFLX   418.03 (-0.44%)
AAPL   322.12 (+1.26%)
MSFT   183.32 (+0.83%)
FB   228.85 (-0.13%)
AMZN   2,421.97 (+0.48%)
NVDA   345.23 (+1.24%)
CGC   21.24 (+6.73%)
BABA   202.01 (+0.41%)
MU   47.51 (-3.92%)
GE   6.85 (-6.17%)
TSLA   815.87 (-0.53%)
ACB   15.56 (+1.70%)
F   5.92 (-1.99%)
DIS   117.48 (-3.34%)
NFLX   418.03 (-0.44%)
AAPL   322.12 (+1.26%)
MSFT   183.32 (+0.83%)
FB   228.85 (-0.13%)
AMZN   2,421.97 (+0.48%)
NVDA   345.23 (+1.24%)
CGC   21.24 (+6.73%)
BABA   202.01 (+0.41%)
MU   47.51 (-3.92%)
GE   6.85 (-6.17%)
TSLA   815.87 (-0.53%)
ACB   15.56 (+1.70%)
F   5.92 (-1.99%)
DIS   117.48 (-3.34%)
NFLX   418.03 (-0.44%)
AAPL   322.12 (+1.26%)
MSFT   183.32 (+0.83%)
FB   228.85 (-0.13%)
AMZN   2,421.97 (+0.48%)
NVDA   345.23 (+1.24%)
CGC   21.24 (+6.73%)
BABA   202.01 (+0.41%)
MU   47.51 (-3.92%)
GE   6.85 (-6.17%)
TSLA   815.87 (-0.53%)
ACB   15.56 (+1.70%)
F   5.92 (-1.99%)
DIS   117.48 (-3.34%)
NFLX   418.03 (-0.44%)
Log in

NASDAQ:PTIProteostasis Therapeutics SEC Filings & 10K Form

$1.33
-0.14 (-9.52 %)
(As of 05/28/2020 02:51 PM ET)
Add
Compare
Today's Range
$1.29
Now: $1.33
$1.52
50-Day Range
$1.11
MA: $1.50
$1.81
52-Week Range
$0.61
Now: $1.33
$4.72
Volume2.44 million shs
Average Volume999,716 shs
Market Capitalization$69.36 million
P/E RatioN/A
Dividend YieldN/A
Beta1.34

SEC Filings

Proteostasis Therapeutics (NASDAQ:PTI) SEC Filings

DateFilerForm TypeView
05/15/2020
3:48 PM
Alfieri Michael (Reporting)
Proteostasis Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/15/2020
3:11 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2020
3:23 PM
Proteostasis Therapeutics (Filer)
Form DEFA14A
04/29/2020
3:21 PM
Proteostasis Therapeutics (Filer)
Form DEF 14A
03/13/2020
4:17 PM
Proteostasis Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/24/2020
7:00 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
3:28 PM
GREAT POINT PARTNERS LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G/A
02/06/2020
2:53 PM
Proteostasis Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
02/06/2020
2:53 PM
Proteostasis Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
01/22/2020
6:00 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
8:20 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
7:30 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2019
6:15 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
12:02 PM
New Enterprise Associates 12, Limited Partnership (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13D/A
12/04/2019
7:10 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2019
6:02 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2019
2:34 PM
BARRIS PETER J (Reporting)
BASKETT FOREST (Reporting)
KERINS PATRICK J (Reporting)
NEA 12 GP, LLC (Reporting)
NEA Partners 12, Limited Partnership (Reporting)
New Enterprise Associates 12, Limited Partnership (Reporting)
Proteostasis Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
8:54 AM
Proteostasis Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2019
3:06 PM
Proteostasis Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
3:05 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
7:00 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2019
7:01 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2019
3:05 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:05 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
4:20 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2019
3:05 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2019
3:25 PM
BlackRock Inc. (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G/A
07/01/2019
3:15 PM
BERGER FRANKLIN M (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
3:14 PM
Kelly Jeffery W. (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
6:01 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:21 PM
Larson Eric D (Reporting)
Proteostasis Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/14/2019
4:11 PM
Chowdhury Badrul A. (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
4:10 PM
Chowdhury Badrul A. (Reporting)
Proteostasis Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/13/2019
4:28 PM
Proteostasis Therapeutics (Filer)
Form 8-K/A
05/13/2019
7:02 AM
Proteostasis Therapeutics (Filer)
Form DEFA14A
05/13/2019
7:00 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
7:07 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
7:06 AM
Proteostasis Therapeutics (Filer)
Form 424B5
05/08/2019
4:16 PM
Proteostasis Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
4:15 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:08 PM
Proteostasis Therapeutics (Filer)
Form DEFA14A
04/30/2019
3:05 PM
Proteostasis Therapeutics (Filer)
Form DEF 14A
03/29/2019
7:30 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2019
6:15 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2019
8:53 PM
1Globe Capital LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G/A
03/08/2019
3:20 PM
Arkowitz David (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
3:17 PM
Arkowitz David (Reporting)
Proteostasis Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/08/2019
3:07 PM
Proteostasis Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/08/2019
3:06 PM
Proteostasis Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2019
3:46 PM
Proteostasis Therapeutics (Issuer)
Zecevic Marija (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:43 PM
Munoz Benito (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:40 PM
Lee Po Shun (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:37 PM
Gilmartin Geoffrey S. (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:35 PM
Chhabra Meenu (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:00 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:02 PM
GREAT POINT PARTNERS LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G/A
02/14/2019
3:02 PM
Cormorant Asset Management, LP (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G/A
02/11/2019
4:03 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2019
3:36 PM
Dulac Emmanuel (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:35 PM
Dulac Emmanuel (Reporting)
Proteostasis Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2019
7:00 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2019
8:25 PM
Drapkin Kimberlee C (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
8:23 PM
Drapkin Kimberlee C (Reporting)
Proteostasis Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/05/2019
7:05 PM
Proteostasis Therapeutics (Issuer)
Zecevic Marija (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
7:04 PM
Munoz Benito (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
7:00 PM
Lee Po Shun (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
6:59 PM
Gilmartin Geoffrey S. (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
6:57 PM
Chhabra Meenu (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
1:32 PM
JENNISON ASSOCIATES LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G/A
01/31/2019
5:20 PM
Proteostasis Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
01/30/2019
3:29 PM
Lee Po Shun (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:31 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2018
3:05 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
6:00 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
11:15 PM
Proteostasis Therapeutics (Filer)
Form EFFECT
11/28/2018
7:00 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/23/2018
3:02 PM
Proteostasis Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/06/2018
3:16 PM
Proteostasis Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
3:01 PM
GREAT POINT PARTNERS LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G
10/26/2018
3:16 PM
BERGER FRANKLIN M (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2018
3:28 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2018
3:21 PM
Proteostasis Therapeutics (Filer)
Form 424B5
10/22/2018
8:50 PM
Proteostasis Therapeutics (Filer)
Form 424B5
10/17/2018
3:30 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2018
7:01 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
3:21 PM
Proteostasis Therapeutics (Issuer)
Zimmerman Sandra M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2018
3:15 PM
Proteostasis Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2018
6:59 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2018
10:44 AM
Proteostasis Therapeutics (Filer)
Form CT ORDER
06/19/2018
3:24 PM
BARRETT M JAMES (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:08 PM
Kelly Jeffery W. (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:07 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2018
3:07 PM
BERGER FRANKLIN M (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
2:39 PM
1Globe Capital LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G
06/06/2018
3:11 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2018
8:05 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2018
8:04 AM
Proteostasis Therapeutics (Filer)
Form DEFA14A
04/26/2018
11:15 PM
Proteostasis Therapeutics (Filer)
Form EFFECT
04/23/2018
7:06 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2018
4:12 PM
Proteostasis Therapeutics (Filer)
Form DEFA14A
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.